Somatostatin receptors and regulation of cell proliferation

被引:41
作者
Bousquet, C [1 ]
Guillermet, J [1 ]
Vernejoul, F [1 ]
Lahlou, H [1 ]
Buscail, L [1 ]
Susini, C [1 ]
机构
[1] CHU Rangueil, INSERM, U531, IFR 31, F-31403 Toulouse 4, France
关键词
antioncogene; apoptosis; inhibition; proliferation; receptors; somatostatin; sst2;
D O I
10.1016/j.dld.2003.11.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Somatostatin is an inhibitory neuropeptide, which acts on various targets throughout the body to regulate a variety of physiological functions including inhibition of endocrine and exocrine secretions, modulation of neurotransmission, motor and cognitive functions, inhibition of intestinal motility, absorption of nutrients and ions, vascular contractility and inhibition of normal and tumour cell proliferation. It exerts its effects through interaction with five somatostatin receptors (sstl-sst5), which belong to the family of G-protein-coupled receptors with seven transmembrane spanning domains and are variably expressed in a variety of tumours such as gastroenteropancreatic tumours, pituitary tumours, and carcinoid tumours. This review covers the present knowledge regarding the molecular mechanisms involved in somatostatin antineoplastic activity. Evidence that sst2 receptor acts as a tumour suppressor is also discussed. (C) 2003 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S2 / S7
页数:6
相关论文
共 63 条
[41]   Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan™ technology [J].
Pinzani, P ;
Orlando, C ;
Raggi, CC ;
Distante, V ;
Valanzano, R ;
Tricarico, C ;
Maggi, M ;
Serio, M ;
Pazzagli, A .
REGULATORY PEPTIDES, 2001, 99 (2-3) :79-86
[42]  
Pollak MN, 1998, P SOC EXP BIOL MED, V217, P143
[43]   Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected ras-transformed NIH 3T3 cells: Coexpression with catalytically inactive SHP-2 blocks responsiveness [J].
Reardon, DB ;
Dent, P ;
Wood, SL ;
Kong, T ;
Sturgill, TW .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (08) :1062-1069
[44]   Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin [J].
Renstrom, E ;
Ding, WG ;
Bokvist, K ;
Rorsman, P .
NEURON, 1996, 17 (03) :513-522
[45]   Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems:: Membranous versus intracellular location [J].
Reubi, JC ;
Waser, B ;
Liu, QS ;
Laissue, JA ;
Schonbrunn, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3882-3891
[46]  
REUBI JC, 1994, CANCER RES, V54, P3455
[47]   Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands [J].
Reubi, JC ;
Waser, B ;
Schaer, JC ;
Laissue, JA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (07) :836-846
[48]   Gene therapy for pancreatic carcinoma:: Local and distant antitumor effects after somatostatin receptor sst2 gene transfer [J].
Rochaix, P ;
Delesque, N ;
Estève, JP ;
Saint-Laurent, N ;
Voigt, JJ ;
Vaysse, N ;
Susini, C ;
Buscail, L .
HUMAN GENE THERAPY, 1999, 10 (06) :995-1008
[49]   Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry [J].
Rohrer, SP ;
Birzin, ET ;
Mosley, RT ;
Berk, SC ;
Hutchins, SM ;
Shen, DM ;
Xiong, YS ;
Hayes, EC ;
Parmar, RM ;
Foor, F ;
Mitra, SW ;
Degrado, SJ ;
Shu, M ;
Klopp, JM ;
Cai, SJ ;
Blake, A ;
Chan, WWS ;
Pasternak, A ;
Yang, LH ;
Patchett, AA ;
Smith, RG ;
Chapman, KT ;
Schaeffer, JM .
SCIENCE, 1998, 282 (5389) :737-740
[50]   A somatostatin receptor 1 selective ligand inhibits Ca2+ currents in rat insulinoma 1046-38 cells [J].
Roosterman, D ;
Glassmeier, G ;
Baumeister, H ;
Scherubl, H ;
Meyerhof, W .
FEBS LETTERS, 1998, 425 (01) :137-140